Anandamide

Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.

Cross Reference

Introduction

To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Anandamide?

Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Anandamide

MeSH term MeSH ID Detail
Reperfusion Injury D015427 65 associated lipids
Pain D010146 64 associated lipids
Nerve Degeneration D009410 53 associated lipids
Fatty Liver D005234 48 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Hyperalgesia D006930 42 associated lipids
Hypotension D007022 41 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Per page 10 20 50 100 | Total 105

PubChem Associated disorders and diseases

What pathways are associated with Anandamide

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Anandamide?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Anandamide?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Anandamide?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Anandamide?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Anandamide?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Anandamide

Download all related citations
Per page 10 20 50 100 | Total 2222
Authors Title Published Journal PubMed Link
Panagis G et al. Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties. 2008 Curr Drug Abuse Rev pmid:19630731
Snider NT et al. The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6. 2008 J. Pharmacol. Exp. Ther. pmid:18698000
Xiong W et al. Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization. 2008 Mol. Pharmacol. pmid:17993512
Hill MN et al. Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. 2008 Hippocampus pmid:18058925
Egertová M et al. Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: A new perspective on N-acylethanolamines as neural signaling molecules. 2008 J. Comp. Neurol. pmid:18067139
Gorzalka BB et al. Endocannabinoid modulation of male rat sexual behavior. 2008 Psychopharmacology (Berl.) pmid:17694389
Rueda-Orozco PE et al. A potential function of endocannabinoids in the selection of a navigation strategy by rats. 2008 Psychopharmacology (Berl.) pmid:17805517
Engeli S et al. Peripheral endocannabinoid system activity in patients treated with sibutramine. 2008 Obesity (Silver Spring) pmid:18356837
Kurtuncu M et al. Effects of cocaine in 5-lipoxygenase-deficient mice. 2008 J Neural Transm pmid:18327533
Wise LE et al. Evaluation of fatty acid amides in the carrageenan-induced paw edema model. 2008 Neuropharmacology pmid:17675189
Solinas M et al. The endocannabinoid system in brain reward processes. 2008 Br. J. Pharmacol. pmid:18414385
Richardson D et al. Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. 2008 Arthritis Res. Ther. pmid:18416822
Farrell EK and Merkler DJ Biosynthesis, degradation and pharmacological importance of the fatty acid amides. 2008 Drug Discov. Today pmid:18598910
Terry G et al. Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents. 2008 Neuroimage pmid:18456516
Yang Z et al. Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine. 2008 Biochem. Pharmacol. pmid:18755158
Wang J et al. Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells. 2008 J. Biochem. pmid:18806270
Murillo-Rodríguez E et al. The anandamide membrane transporter inhibitor, VDM-11, modulates sleep and c-Fos expression in the rat brain. 2008 Neuroscience pmid:18822353
Woo DH et al. Direct activation of transient receptor potential vanilloid 1(TRPV1) by diacylglycerol (DAG). 2008 Mol Pain pmid:18826653
DeMorrow S et al. The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway. 2008 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:18832445
Bambico FR and Gobbi G The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. 2008 Expert Opin. Ther. Targets pmid:18851692
Ellgren M et al. Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. 2008 Eur Neuropsychopharmacol pmid:18674887
Fowler CJ and Ghafouri N Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake? 2008 Pharmacol. Res. pmid:18675915
Hashiguchi T et al. Systematic evaluation of nitric oxide, tetrahydrobiopterin, and anandamide levels in a porcine model of endotoxemia. 2008 J Anesth pmid:18685926
Lisboa SF et al. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test. 2008 Eur. J. Pharmacol. pmid:18691568
Currie S et al. IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei. 2008 J. Mol. Cell. Cardiol. pmid:18692061
Turco MY et al. High levels of anandamide, an endogenous cannabinoid, block the growth of sheep preimplantation embryos by inducing apoptosis and reversible arrest of cell proliferation. 2008 Hum. Reprod. pmid:18614613
Maccarrone M Anandamide as a marker of human disease. 2008 JAMA pmid:18632539
Hill MN et al. Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. 2008 J. Neurochem. pmid:18643796
Kudo R and Hatake K [Effect of ethanol on anandamide-induced sensory nerve dependent vasorelaxation (the second report)]. 2008 Nihon Arukoru Yakubutsu Igakkai Zasshi pmid:18646646
Bjursell M et al. Acutely reduced locomotor activity is a major contributor to Western diet-induced obesity in mice. 2008 Am. J. Physiol. Endocrinol. Metab. pmid:18029443
Williams MA et al. The group IV afferent neuron expresses multiple receptor alterations in cardiomyopathyic rats: evidence at the cannabinoid CB1 receptor. 2008 J. Physiol. (Lond.) pmid:18063665
Justinova Z et al. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. 2008 Biol. Psychiatry pmid:18814866
Muccioli GG and Stella N An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain. 2008 Anal. Biochem. pmid:17981259
Thiemann G et al. The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization. 2008 Behav. Brain Res. pmid:17988751
Correa F et al. Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2). 2008 Biochem. J. pmid:17961121
Sakamoto Y et al. Effectiveness of continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter after polymyxin B-immobilized fiber column therapy of septic shock. 2008 Jan-Feb ASAIO J. pmid:18204329
Lissoni P et al. The endocannabinoid anandamide neither impairs in vitro T-cell function nor induces regulatory T-cell generation. 2008 Nov-Dec Anticancer Res. pmid:19189659
Kurjak M et al. Differential stimulatory effects of cannabinoids on VIP release and NO synthase activity in synaptosomal fractions from rat ileum. 2008 Oct-Dec Neuropeptides pmid:18829105
Ferreira SG et al. N-acyldopamines control striatal input terminals via novel ligand-gated cation channels. 2009 Neuropharmacology pmid:19101577
Ozalp A and Barroso B Simultaneous quantitative analysis of N-acylethanolamides in clinical samples. 2009 Anal. Biochem. pmid:19665986
Li D et al. Role of anandamide transporter in regulating calcitonin gene-related peptide production and blood pressure in hypertension. 2009 J. Hypertens. pmid:19462497
Mahmud A et al. Cannabinoid 1 receptor activation inhibits transient receptor potential vanilloid type 1 receptor-mediated cationic influx into rat cultured primary sensory neurons. 2009 Neuroscience pmid:19463903
Vann RE et al. Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice. 2009 Eur. J. Pharmacol. pmid:19470387
Vercelli CA et al. Anandamide regulates lipopolysaccharide-induced nitric oxide synthesis and tissue damage in the murine uterus. 2009 Reprod. Biomed. Online pmid:19490788
Aquila S et al. A new role of anandamide in human sperm: focus on metabolism. 2009 J. Cell. Physiol. pmid:19492411
Kingsley PJ and Marnett LJ Analysis of endocannabinoids, their congeners and COX-2 metabolites. 2009 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:19505857
Dowie MJ et al. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease. 2009 Neuroscience pmid:19524019
Wise LE et al. Fatty acid amide hydrolase (FAAH) knockout mice exhibit enhanced acquisition of an aversive, but not of an appetitive, Barnes maze task. 2009 Neurobiol Learn Mem pmid:19524055
Maeda N et al. Increased serum anandamide level at ruptured plaque site in patients with acute myocardial infarction. 2009 Fundam Clin Pharmacol pmid:19527302
Straiker A and Mackie K Cannabinoid signaling in inhibitory autaptic hippocampal neurons. 2009 Neuroscience pmid:19501632
Kinsey SG et al. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. 2009 J. Pharmacol. Exp. Ther. pmid:19502530
Brighton PJ et al. Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells. 2009 Mol. Endocrinol. pmid:19477951
Yates ML and Barker EL Organized trafficking of anandamide and related lipids. 2009 Vitam. Horm. pmid:19647107
Goodfellow CE and Glass M Anandamide receptor signal transduction. 2009 Vitam. Horm. pmid:19647109
Brown AJ and Robin Hiley C Is GPR55 an anandamide receptor? 2009 Vitam. Horm. pmid:19647110
Correa FG et al. The endocannabinoid anandamide from immunomodulation to neuroprotection. Implications for multiple sclerosis. 2009 Vitam. Horm. pmid:19647114
Tóth A et al. Anandamide and the vanilloid receptor (TRPV1). 2009 Vitam. Horm. pmid:19647120
Pasquariello N et al. Regulation of gene transcription and keratinocyte differentiation by anandamide. 2009 Vitam. Horm. pmid:19647122
Alpini G and Demorrow S Changes in the endocannabinoid system may give insight into new and effective treatments for cancer. 2009 Vitam. Horm. pmid:19647123
Astarita G et al. Targeted lipidomics as a tool to investigate endocannabinoid function. 2009 Int. Rev. Neurobiol. pmid:19607960
Francavilla F et al. Characterization of the endocannabinoid system in human spermatozoa and involvement of transient receptor potential vanilloid 1 receptor in their fertilizing ability. 2009 Endocrinology pmid:19608651
Centonze D et al. Altered anandamide degradation in attention-deficit/hyperactivity disorder. 2009 Neurology pmid:19398708
Liu H et al. Endocannabinoids anandamide and its cannabinoid receptors in liver fibrosis after murine schistosomiasis. 2009 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:19399401
Mazzola C et al. Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. 2009 Learn. Mem. pmid:19403796
Shen Y et al. A transient receptor potential-like channel mediates synaptic transmission in rod bipolar cells. 2009 J. Neurosci. pmid:19439586
Balas L et al. Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity. 2009 J. Med. Chem. pmid:19161308
Gardiner SM et al. Factors influencing the regional haemodynamic responses to methanandamide and anandamide in conscious rats. 2009 Br. J. Pharmacol. pmid:19702785
Guindon J and Hohmann AG The endocannabinoid system and pain. 2009 CNS Neurol Disord Drug Targets pmid:19839937
Karaliota S et al. Anandamide increases the differentiation of rat adipocytes and causes PPARgamma and CB1 receptor upregulation. 2009 Obesity (Silver Spring) pmid:19543211
Marco EM and Viveros MP The critical role of the endocannabinoid system in emotional homeostasis: avoiding excess and deficiencies. 2009 Mini Rev Med Chem pmid:19929814
Vercelli CA et al. Endocannabinoid system and nitric oxide are involved in the deleterious effects of lipopolysaccharide on murine decidua. 2009 Placenta pmid:19428101
Li Q et al. Electrophysiological effects of anandamide on rat myocardium. 2009 Br. J. Pharmacol. pmid:20050190
Hiley CR Endocannabinoids and the heart. 2009 J. Cardiovasc. Pharmacol. pmid:19276990
Gratzke C et al. Distribution and function of cannabinoid receptors 1 and 2 in the rat, monkey and human bladder. 2009 J. Urol. pmid:19237169
El-Talatini MR et al. Localisation and function of the endocannabinoid system in the human ovary. 2009 PLoS ONE pmid:19238202
Parker LA et al. The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew). 2009 Physiol. Behav. pmid:19239915
Schlosburg JE et al. Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation. 2009 AAPS J pmid:19184452
Tang B et al. Endothelin-1 inhibits background two-pore domain channel TASK-1 in primary human pulmonary artery smooth muscle cells. 2009 Am. J. Respir. Cell Mol. Biol. pmid:19188660
McCue JM et al. In vitro synthesis of arachidonoyl amino acids by cytochrome c. 2009 Prostaglandins Other Lipid Mediat. pmid:19683594
Cottone E et al. Goldfish CB1 mRNA expression is affected by fasting and anandamide administration. 2009 Neuroreport pmid:19293731
Villanueva A et al. Central cannabinoid 1 receptor antagonist administration prevents endotoxic hypotension affecting norepinephrine release in the preoptic anterior hypothalamic area. 2009 Shock pmid:19295473
Izzo AA et al. Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. 2009 Br. J. Pharmacol. pmid:19371345
Appendino G et al. Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes. 2009 J. Med. Chem. pmid:19361197
El-Talatini MR et al. Fluctuation in anandamide levels from ovulation to early pregnancy in in-vitro fertilization-embryo transfer women, and its hormonal regulation. 2009 Hum. Reprod. pmid:19363040
Brizzi A et al. New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivo. 2009 J. Med. Chem. pmid:19331413
Koethe D et al. Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis. 2009 Br J Psychiatry pmid:19336792
Mangieri RA et al. An endocannabinoid signal associated with desire for alcohol is suppressed in recently abstinent alcoholics. 2009 Psychopharmacology (Berl.) pmid:19343330
Potenzieri C et al. Excitation of cutaneous C nociceptors by intraplantar administration of anandamide. 2009 Brain Res. pmid:19285051
De Petrocellis L and Di Marzo V An introduction to the endocannabinoid system: from the early to the latest concepts. 2009 Best Pract. Res. Clin. Endocrinol. Metab. pmid:19285257
Borrelli F and Izzo AA Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance. 2009 Best Pract. Res. Clin. Endocrinol. Metab. pmid:19285259
Bermúdez-Silva FJ et al. The role of the pancreatic endocannabinoid system in glucose metabolism. 2009 Best Pract. Res. Clin. Endocrinol. Metab. pmid:19285263
Rossi F et al. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption. 2009 Bone pmid:19059369
Jiang LS et al. Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages. 2009 Cardiovasc. Res. pmid:19074161
Aneetha H et al. Alcohol dehydrogenase-catalyzed in vitro oxidation of anandamide to N-arachidonoyl glycine, a lipid mediator: synthesis of N-acyl glycinals. 2009 Bioorg. Med. Chem. Lett. pmid:19013794
Panlilio LV et al. Anandamide-induced behavioral disruption through a vanilloid-dependent mechanism in rats. 2009 Psychopharmacology (Berl.) pmid:19015836
De Petrocellis L et al. Chemical synthesis, pharmacological characterization, and possible formation in unicellular fungi of 3-hydroxy-anandamide. 2009 J. Lipid Res. pmid:19017617
Tuboly G et al. Antinociceptive interactions between anandamide and endomorphin-1 at the spinal level. 2009 Clin. Exp. Pharmacol. Physiol. pmid:19018802
Schacht JP et al. Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis. 2009 Psychopharmacology (Berl.) pmid:19002671
Araújo JR et al. Effect of cannabinoids upon the uptake of folic acid by BeWo cells. 2009 Pharmacology pmid:19145103
Van Dross RT Metabolism of anandamide by COX-2 is necessary for endocannabinoid-induced cell death in tumorigenic keratinocytes. 2009 Mol. Carcinog. pmid:19148897